
Wellcome responds to US cuts to global health and research funding
John-Arne Røttingen, chief executive of Wellcome, responds to US cuts to global health and research funding
John-Arne Røttingen, chief executive of Wellcome, said:
“Research excellence, investment in research and global collaboration are the bedrock for advancing health through science. And good health and health security are fundamental for the strong economies and societies all nations desire. Decisions to make substantial cuts to funding available to global health and health research pose significant challenges.
"Wellcome is monitoring the impact on our programmes and partners. We know, for example, that Wellcome’s major international programmes in Africa and Asia are among those experiencing direct and indirect impacts. As we continue to assess the situation, we are exploring what options might exist for Wellcome in our support of science and for the wider research ecosystem. However, while we are a major global supporter of science to advance health equity and global health, our contribution is a drop in the ocean compared to what governments across the world need to provide.”